Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-035890
Filing Date
2021-09-14
Accepted
2021-09-14 18:45:20
Documents
2
Period of Report
2021-09-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 9933
2 EX-24 DOCUMENT attachment1.htm EX-24 6564
  Complete submission text file 0000899243-21-035890.txt   19620
Mailing Address 285 RIVERSIDE AVENUE SUITE 250 WESTPORT CT 06880
Business Address 285 RIVERSIDE AVENUE SUITE 250 WESTPORT CT 06880 203-855-0400
Canaan XI L.P. (Reporting) CIK: 0001712417 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-40800 | Film No.: 211253667

Mailing Address 285 RIVERSIDE AVENUE, SUITE 250 WESTPORT CT 06880
Business Address 285 RIVERSIDE AVENUE, SUITE 250 WESTPORT CT 06880 203-855-0400
Canaan Partners XI LLC (Reporting) CIK: 0001850694 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-40800 | Film No.: 211253666

Mailing Address 2656 STATE STREET CARLSBAD CA 92008
Business Address 2656 STATE STREET CARLSBAD CA 92008 (619) 728-4760
Tyra Biosciences, Inc. (Issuer) CIK: 0001863127 (see all company filings)

EIN.: 831476348 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2765 SAND HILL ROAD MENLO PARK CA 94065
Business Address 2765 SAND HILL ROAD MENLO PARK CA 94065 203-682-4427
Canaan Partners 2020+ Co-Investment LLC (Reporting) CIK: 0001881618 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-40800 | Film No.: 211253664

Mailing Address 2765 SAND HILL ROAD MENLO PARK CA 94025
Business Address 2765 SAND HILL ROAD MENLO PARK CA 94025 203-682-4427
Canaan 2020+ Co-Investment L.P. Series 7 (Reporting) CIK: 0001882023 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-40800 | Film No.: 211253665